ASPRE trial: performance of screening for preterm pre‐eclampsia

This is the authors' abstract. We don't add key points for this paper.

The performance of screening in the ASPRE study was comparable with that of a study of approximately 60 000 singleton pregnancies used for development of the algorithm; in that study, combined screening detected 76.6% of cases of preterm PE and 38.3% of term PE at a FPR of 10%.